Yolanda K. Prado

Dynamic Project Manager with extensive experience at Kaiser Permanente, Center for Health Research, excelling in project management and stakeholder engagement. Proven track record in managing multimillion-dollar budgets and leading cross-functional teams to successful project outcomes. Adept at strategic planning and grant administration, ensuring compliance and enhancing research capabilities. Experienced at conducting and managing Phase I-III clinical trials in oncology, immunology, vaccines, Alzheimer's and dementia, pediatric CNS, and organ transplant.

• Herpes zoster diagnosis and treatment in relation to incident dementia: A population based retrospective matched cohort study, Sheila Weinmann, Andreea Rawlings, Padma Koppolu, A. Gabriela Rosales, Yolanda K. Prado, Mark A. Schmidt, PLoS One, 01/25/24, 10.1371/journal.pone.0296957, PMC10810473
• Genetic Testing Uptake among Ovarian Cancer Survivors in the Genetic Risk Analysis in Ovarian Cancer (GRACE) Study, Larissa L. White, Jennifer K. Sawyer, Jamilyn M. Zepp, Yolanda K. Prado, Ana A. Reyes, Mahesh Maiyani, Elizabeth Shuster, Rachel Zucker, Nora B. Henrikson, Alan F. Rope, Sheila Weinmann, Heather S. Feigelson, Jessica Ezzell Hunter, Cancers (Basel), 07/17/24, 10.3390/cancers16142563, PMC11274893
• An Examination of the Ethical and Legal Limits in Implementing “Traceback Testing” for Deceased Patients, Jessica Martucci, Yolanda Prado, Alan F. Rope, Sheila Weinmann, Larissa White, Jamilyn Zepp, Nora B. Henrikson, Heather Spencer Feigelson, Jessica Ezzell Hunter, J Law Med Ethics, Winter 2022, 10.1017/jme.2023.23, PMC10009393
• Developing an algorithm across integrated healthcare systems to identify a history of cancer using electronic medical records, Jennifer C Gander, Mahesh Maiyani, Larissa L White, Andrew T Sterrett, Brianna Güney, Pamala A Pawloski, Teri DeFor, YuanYuan Olsen, Benjamin A Rybicki, Christine NeslundDudas, Darsheen Sheth, Richard Krajenta, Devaki Purushothaman, Stacey Honda, Cyndee Yonehara, Katrina A B Goddard, Yolanda K Prado, Habibul Ahsan, Muhammad G Kibriya, Briseis AschebrookKilfoy, ChunHung Chan, Sarah Hague, Christina L Clarke, Brooke Thompson, Jennifer Sawyer, Mia M Gaudet, Heather Spencer Feigelson, Am Med Inform Assoc, 07/29/22, 10.1093/jamia/ocac044, PMC9196704
• Quantifying cancer risk from exposures to medical imaging in the Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging (RIC) Study: Research Methods and Cohort Profile, Marilyn L Kwan, Diana L Miglioretti, Erin JA Bowles, Sheila Weinmann, Robert T Greenlee, Natasha K Stout, Alanna Kulchak Rahm, Susan A Alber, Priscila Pequeno, Lisa M Moy, Carly Stewart, Cindy Fong, Charisma L. Jenkins, Diane Kohnhorst, Casey Luce, Joanne M Mor, Julie R Munneke, Yolanda Prado, Glen Buth, Stephanie Y Cheng, Kamala A Deosaransingh, Melanie Francisco, Matthew Lakoma, Yannica Theda Martinez, Mary Kay Theis, Emily C Marlow, Lawrence H Kushi, James R Duncan, Wesley E Bolch, Jason D Pole, Rebecca SmithBindman, Cancer Causes Control, 02/02/22, 10.1007/s1055202201556z, PMC9596345
• Feasibility of a Traceback Approach for Using Pathology Specimens to Facilitate Genetic Testing in the Genetic Risk Analysis in Ovarian Cancer (GRACE) Study Protocol, Tia L. Kauffman, Yolanda K. Prado, Ana A. Reyes, Jamilyn M. Zepp, Jennifer Sawyer, Larissa Lee White, Jessica Martucci, Suzanne Bianca Salas, Sarah Vertrees, Alan F. Rope, Sheila Weinmann, Nora B. Henrikson, Sandra SooJin Lee, Heather Spencer Feigelson, Jessica Ezzell Hunter, J Pers Med, 11/13/21, 10.3390/jpm11111194, PMC8625870
• A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration resistant prostate cancer progressing on enzalutamide alone, Graff JN, Beer TM, Alumkal JJ, Slottke RE, Redmond WL, Thomas GV, Thompson RF, Wood MA, Koguchi Y, Chen Y, Latour E, Bergan RC, Drake CG, Moran AE, J Immunotherapy Cancer, 07/01/20, 10.1136/jitc-2020-000642, PMC7333874

https://www.linkedin.com/in/yolanda-k-prado/details/recommendations/